Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Brodalumab is an effective therapy among patients with psoriasis who have failed prior biologic therapy or had risk factors for treatment failure.

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...

Alex Thompson CFA, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Oruka Therapeutics (ORKA). Alex Thompson CFA has given ...

Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer.

The primary endpoint was clinical remission at week 12, with secondary endpoints of clinical response and endoscopic ...

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...